Eloxx Pharmaceuticals, Inc.
USD1.51
-2.56 (-62.90%)
CEO
Sumit Aggarwal
IPO Date
1999-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.36
Prev. Close
$4.07
Day Low
$0.36
Day High
$1.51
52W Low
$0.00
52W High
$8.25
Market Cap
$0.01B
Volume
0.00M
| $0.00 |
| 29 May 2026 | Coastlands Capital LP | 10 percent owner | J-Other | Disposed | 1,250,000 | $0.00 |
| 29 May 2026 | Coastlands Capital LP | 10 percent owner | J-Other | Acquired | 1,250,000 | $0.01 |
| 8 May 2026 | Rubin Steven D | director | M-Exempt | Acquired | 1,875 | $0.00 |
| 8 May 2026 | Rubin Steven D | director | A-Award | Acquired | 179,854 | $0.15 |
| 8 May 2026 | Rubin Steven D | director | M-Exempt | Disposed | 1,875 | $0.00 |
| 8 May 2026 | Aggarwal Sumit | director, 10 percent owner, officer: President and CEO | M-Exempt | Acquired | 196,880 | $0.00 |
| 8 May 2026 | Aggarwal Sumit | director, 10 percent owner, officer: President and CEO | A-Award | Acquired | 1,000,000 | $0.00 |
| 8 May 2026 | Aggarwal Sumit | director, 10 percent owner, officer: President and CEO | M-Exempt | Acquired | 15,000 | $0.00 |